BuildMyBod Founder speaking at ASDS!

asds

Dr. Kaplan, founder/CEO of BuildMyBod Health will be speaking at the American Society of Dermatologic Surgery (ASDS) annual meeting this weekend. The American Society for Dermatologic Surgery (ASDS) is the largest specialty organization in the United States exclusively representing dermatologic surgeons who have unique training and experience to treat the health, function and beauty of skin throughout every stage of life. ASDS members are recognized as leaders in the field of cosmetic and medically necessary skin surgery.

 

Lecture at ASDS

Dr. Kaplan’s talk is entitled, “How to monetize your social media followers.” This talk will explain how to take all that hard work and effort in producing content for social media, and converting those followers into patients.

 

Creating content for social media is a tough, nonstop effort. So you might as well get something in return. Dr. Kaplan will explain how you can better get your followers into your sales funnel. So rather than just having a collection of social media followers with nebulous handles, you can get their contact info through a variety of techniques.

 

And more than just capturing social media followers, you should also be getting the contact info from your website traffic. Traffic by itself isn’t good enough because you can’t follow a click!

 

If you’re going to be at the ASDS meeting this weekend, come by and check out Dr. Kaplan’s presentation at 1:45p on Saturday during the PR, Media and Reputation Management section of the meeting.

 

Share:

Facebook
Twitter
Pinterest
LinkedIn
On Key

Related Posts

Are we all obesity medicine doctors now?

Providers considering offering weight loss medications to their existing or new patients may be reluctant if they’re not obesity medicine specialists. However, those providers may

Join over 7,000+ providers receiving insights in their inbox to boost their revenue and help their patient satisfaction with our turn-key weight management program.

This field is for validation purposes and should be left unchanged.